arrow
R

Richard Croker

university of oxford
H指数:26
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak: retrospective cohort study in England using OpenSAFELY-TPP
2024-05-245
OAAI
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate

OpenSAFELY: 新型冠状病毒肺炎对硫唑嘌呤,来氟米特和甲氨蝶呤监测的影响,以及与监测率变化相关的因素

2024-04-080
OAAI
The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records

新型冠状病毒肺炎对英语初级保健中药物评论的影响。2000万份成人电子健康档案的OpenSAFELY-TPP分析

2024-03-260
OAAI
Eleven key measures for monitoring general practice clinical activity during COVID-19: A retrospective cohort study using 48 million adults' primary care records in England through OpenSAFELY
2023-07-271
OA
Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analytics

使用OpenSAFELY在整个新型冠状病毒肺炎大流行期间英国药物安全性指标的变化: 使用联邦分析对5700万名患者进行的基于人群的回顾性队列研究

2023-05-196
OAAI
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data

使用观察数据估计新型冠状病毒肺炎疫苗接种有效性的挑战

2023-05-0112
OA
OpenSAFELY NHS Service Restoration Observatory 2: changes in primary care clinical activity in England during the COVID-19 pandemic

OpenSAFELY NHS服务恢复观察站2: 新型冠状病毒肺炎大流行期间英格兰初级保健临床活动的变化

2023-02-017
OAAI
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

社区环境中抗病毒药物和中和单克隆抗体新型冠状病毒肺炎接受者的趋势,变化和临床特征: 对OpenSAFELY 2340万人的回顾性描述性队列研究

2023-01-139
OAAI
Identifying Patterns of Clinical Interest in Clinicians? Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review

确定临床医生的临床兴趣模式?治疗偏好: 无假设的数据科学方法优先考虑临床审查的异常值

2022-12-201
OAAI
Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY

ChAdOx1与BNT162b2新型冠状病毒肺炎疫苗在英格兰卫生和社会护理工作者中的比较有效性: 使用OpenSAFELY的队列研究

2022-07-2010
OAAI
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
2022-07-2036
OAAI
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform

与免疫介导的炎症性疾病和免疫修饰疗法相关的严重新型冠状病毒肺炎结局风险: OpenSAFELY平台的一项全国性队列研究

2022-07-0168
OAAI
Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY

对机械心脏瓣膜患者可能不适当的doac处方: 使用OpenSAFELY对5790万名患者的初级保健记录进行联合分析

2022-03-014
OAAI
Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65

新型冠状病毒肺炎大流行第一波和第二波期间英格兰疗养院居民的死亡率: 一项对430万名65岁以上成年人的观察性研究

2022-03-0130
OA
Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study

与直接口服抗凝药相比,华法林与COVID-19-related结局之间的关系: 基于人群的队列研究

2021-10-1911
OAAI